CEO MONTHLY Ι GLOBAL CEO EXCELLENCE AWARDS 2024 9 Jul24694 individuals across the world. By regularly collecting and analysing feedback from professionals, SuperSonic Imagine® can make the adjustments that matter, upgrading its software, refining its products, and developing new solutions based on the evolving needs of patients, doctors, and healthcare providers. “Additionally,” Sandeep adds, “we are committed to addressing the challenge of rural access. Unlike many medical devices that are not customised for local needs, our products are specifically tailored to meet demographic and regional requirements. Even our future AI development is designed to learn and deliver local demographics, ensuring that our technology remains relevant and effective in diverse patient needs and settings .” Between integrating feedback patients and professionals alike and striving towards healthcare accessibility in rural areas, SuperSonic Imagine® is making waves in the healthcare industry. The company is pushing for accessibility in all areas of the sector and has successfully opened the often-blocked doors to healthcare worldwide. Of course, such marked levels of success are made possible under the expert leadership of Sandeep. He believes in empowering the team, granting them autonomy in order to foster success. “I firmly believe that when individuals have the freedom to pursue their own goals, they contribute to the overall success of the organisation ” he says. This approach involves establishing clear priorities within the team, developing strategic plans, painting a clear picture of what common success looks like, and instilling a vision for the future. In doing so, Sandeep enables his team to achieve success, which in turn contributes to the collective success of SuperSonic Imagine® and its mission of enhancing patients’ lives. The company’s mission is to enhance the lives of patients across the globe through its development and use of cutting-edge technologies. SuperSonic Imagine®’s products stand out in the market due to their exceptional technical prowess. Its ultrasound technologies feature Plane Wave technology, a unique selling point for our technology. Additionally, the SuperSonic® Vi PL.U.S.™ technology excels in visualisation, quantification of tissue viscosity , Additionally, the SuperSonic® Vi PL.U.S™ technology excels in visualisation, quantification of tissue viscosity along with SuperSonic® Q-Liver PL.U.S to assess fatty liver disease. SuperSonic Imagine®’s approach to the ultrasound technology provides unparalleled specificity and accuracy. Furthermore, the company’s use of matrix imaging, incorporating gaming technology to further enhance image quality, is an unprecedented innovation in the field of ultrasound. Despite such advancements, SuperSonic Imagine® has encountered challenges on its journey. “Reaching every patient globally remains a challenge,” Sandeep tells us. “Our goal is to extend the reach of this cutting-edge technology to the most and especially remote areas, equipping radiographers and sonographers with the tools for early detection and livesaving imaging diagnostics. Our teams are committed to this mission, and hence we actively seek partnerships to broaden our impact and improve accessibility. By collaborating with OEMs and expanding our presence, we aim to ensure that our technology benefits those who need it most.” Looking ahead, SuperSonic Imagine® plans to continue with its mission, delivering high quality ultrasound technology to healthcare professionals around the world. With this mission comes the launch of HEPAVu™, a ground-breaking liver-focused ultrasound technology that promises to revolutionise how liver specialists, sonographers, doctors, and physicians assess liver conditions. Not only will HEPAVu ™ measure fat fraction but it will also provide detailed imaging capable of detecting even the slightest indications of fibrosis, unique biomarkers for liver steatosis assessment, and enhance early detection capabilities. Additionally, SuperSonic Imagine® has recently released its latest software upgrade, MACH® V4.2, setting a new standard in ultrasound technology with enhanced image quality to provide more detailed diagnostics across various clinical applications. The upgrade brings advanced software capabilities, optimised workflow, superior diagnostic accuracy, and an enhanced user experience. The company also has its sights set on expanding its manufacturing capabilities, with plans to establish new sites in India and China. These facilities will bring SuperSonic Imagine®’s products closer to the market and enable it to better serve developing regions, where accessibility is needed most. Since its inception, SuperSonic Imagine® has been steadfast in its mission to bringing meaningful change to the healthcare industry. Sandeep has shown an unwavering commitment to leveraging innovation and the latest technologies to deliver effective, accessible solutions. Under his expert guidance, the company has gone from strength to strength, demonstrating exactly why Sandeep Wadhwa has been recognised as the Most Informative CEO for Hepatology & Gastroenterology in 2024 -France. We would like to congratulate Sandeep and look forward to seeing what is next for the innovator as he continues to lead SuperSonic Imagine ® to great heights. We ask Sandeep what his future holds within the healthcare industry. “Alongside my partners, Sanju Nair and Hari Kaimal, we are dedicated to driving SuperSonic Imagine®’s growth and revolutionising ultrasound technology,” he tells us. “Our focus is on leveraging game-changing innovations to enable early detection and improve access to healthcare in rural areas.” Contact: Sandeep Wadhwa Company: SuperSonic Imagine® Web Address: www.supersonicimagine.com SUPERSONIC
RkJQdWJsaXNoZXIy NTY1MjI4